Brief: Optimi Health Finalizes Partnership And Psilocybin Supply Agreement With Atma Journey Centers
08/06/2022 14:16
June 8 (Reuters) - Optimi Health Corp OPTI.CD :
* OPTIMI HEALTH FINALIZES PARTNERSHIP AND PSILOCYBIN SUPPLY
AGREEMENT WITH ATMA JOURNEY CENTERS
* OPTIMI HEALTH - FINALIZED AN AGREEMENT WHICH WILL SUPPLY
PSILOCYBIN PRODUCTS TO ATMA FOR FUTURE THERAPIST INITIATIVES AND
SUPPLY REQUIREMENTS
Source text for Eikon: ID:nGNX4RvsL6
Further company coverage: OPTI.CD
((reuters.briefs@thomsonreuters.com;))
Recent news on Optimi Health
See all newsExplainer: As Trump backs psychedelics research, FDA weighs safety and access standards
Brief: Optimi Health Corp - Trial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027
Brief: Optimi Health Offers 2.4 MLn Common Shares At A Public Offering Price Of US$6.25 Per Share
Brief: Optimi Health Corp Now Sees IPO Of 2.4 Million Common Shares
Trump's psychedelic drug order boosts investor interest with promise of faster reviews